Your browser doesn't support javascript.
loading
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model.
García-Otero, Xurxo; Mondelo-García, Cristina; Bandín-Vilar, Enrique; Gómez-Lado, Noemí; Silva-Rodríguez, Jesús; Rey-Bretal, David; Victoria Otero-Espinar, M; Adan, Alfredo; González-Barcia, Miguel; Aguiar, Pablo; Otero-Espinar, Francisco J; Fernández-Ferreiro, Anxo.
Afiliación
  • García-Otero X; Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15705 Santiago de Compostela, Spain; Molecular Imaging Biomarkers and Nuclear Medicine Department, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santi
  • Mondelo-García C; Clinical Pharmacology Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain; Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.
  • Bandín-Vilar E; Clinical Pharmacology Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain; Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.
  • Gómez-Lado N; Molecular Imaging Biomarkers and Pharmacokinetic Modelling (MIBIOPHARM), Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain; Preclinical Imaging Facility, Experimental Biomedicine Centre (CEBEGA), Un
  • Silva-Rodríguez J; Molecular Imaging Biomarkers and Nuclear Medicine Department, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
  • Rey-Bretal D; Molecular Imaging Biomarkers and Nuclear Medicine Department, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
  • Victoria Otero-Espinar M; Statistics, Mathematical Analysis and Optimisation Department, Faculty of Mathematics, University of Santiago de Compostela (USC), and Galician Center for Mathematical Research and Technology (CITMAga), 15782 Santiago de Compostela, Spain.
  • Adan A; Department of Ophthalmology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.
  • González-Barcia M; Clinical Pharmacology Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain; Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.
  • Aguiar P; Molecular Imaging Biomarkers and Nuclear Medicine Department, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain; Molecular Imaging Biomarkers and Pharmacokinetic Modelling (MIBIOPHARM), Centre for Research in Molecular Medicine and Chronic Diseases (CIMU
  • Otero-Espinar FJ; Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15705 Santiago de Compostela, Spain; Paraquasil Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compost
  • Fernández-Ferreiro A; Clinical Pharmacology Group, University Clinical Hospital, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain; Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain. Electronic address: a
Int J Pharm ; 627: 122261, 2022 Nov 05.
Article en En | MEDLINE | ID: mdl-36208838

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Uveítis Límite: Animals Idioma: En Revista: Int J Pharm Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Uveítis Límite: Animals Idioma: En Revista: Int J Pharm Año: 2022 Tipo del documento: Article